Atlas Trials

Influenza Vaccine Post Allogeneic Transplant

Clinical trial NCT01215981 · TERMINATED

Trial details

NCT number
NCT01215981
Sponsor
Masonic Cancer Center, University of Minnesota
Status
TERMINATED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hematopoietic Stem Cell TransplantHematologic Malignancy
Start date
2010-09-01
Primary completion
2011-06-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.